Concurrent Use of and (COB-

NQF Endorsement Status Endorsed

NQF ID 3389

Measure Type Process

Measure Content Last Updated 2021-06-30

Info As Of Not Available

Properties

Description Percentage of Medicaid beneficiaries age 18 and older with concurrent use of prescription opioids and benzodiazepines.

Numerator The number of individuals from the denominator with: Two or more prescription claims for any (Table COB-B) with unique dates of service, AND Concurrent use of opioids and benzodiazepines for 30 or more cumulative days. Table COB-B. Benzodiazepinesa Benzodiazepine Medications Quazepam

Denominator Age 18 and older as of January 1 of the measurement year. Identify individuals with 2 or more prescriptions for opioids (Table COB-A) with unique dates of service, for which the sum of the days supply is 15 or more during the measurement year. Exclude individuals who met at least one of the following during the

Report Generated: Sun Oct 03 03:11:28 EDT 2021 | Page 1

Concurrent Use of Opioids and Benzodiazepines (COB-

measurement year: Hospice Cancer Diagnosis Table COB-A. Medications Opioid Medications Buprenorphinec Butorphanol Codeine Dihydrocodeine Fentanyld Hydrocodone Hydromorphone Levorphanol Meperidine Methadone Opium Oxycodone Oxymorphone Pentazocine Tapentadol Tramadol

Denominator Exclusions Beneficiaries with cancer are excluded from this measure and may be identified using the ICD-10 codes in Table COB-C, available at https://www.medicaid.gov/license-agreement.html file=%2Fmedicaid%2Fquality-of-care%2Fdownloads%2F2018-adult-non-hedis- value-set-directory.zip. The cancer exclusion criterion is for beneficiaries with a diagnosis code for cancer during the measurement year. Their initial diagnosis may have occurred previously; however, the diagnosis code for cancer must be present

Rationale Not Available

Evidence Not Available

Developer/Steward

Steward Pharmacy Quality Alliance

Contact Not Available

Measure Developer Not Available

Report Generated: Sun Oct 03 03:11:28 EDT 2021 | Page 2

Concurrent Use of Opioids and Benzodiazepines (COB-

Development Stage Fully Developed

Characteristics

Measure Type Process

Meaningful Measure Area Not Available

Healthcare Priority Making Care Safer by Reducing Harm Caused in the Delivery of Care eCQM Spec Available No

NQF Endorsement Status Endorsed

NQF ID 3389

Last NQF Update 2020-10-19

Target Population Age 18+

Target Population Age (High) Not Available

Target Population Age (Low) 18

Reporting Level Not Available

Conditions Substance Abuse

Subconditions Opioid Dependency

Care Settings Hospital Outpatient; Other; Outpatient

Groups

Core Measure Set Medicaid Adult Core Set

Measure Group Group Identifier

Adult Core Set

Report Generated: Sun Oct 03 03:11:28 EDT 2021 | Page 3

Concurrent Use of Opioids and Benzodiazepines (COB-

Measure Links

Measure Program: Medicaid

Info As Of Not Available

Program / Model Notes

Data Sources Claims Data

Purposes Not Available

Quality Domain Not Available

Reporting Frequency Not Available

Impacts Payment No

Reporting Status Active

Data Reporting Begin Date 2018-10-01

Data Reporting End Date Not Available

Measure Program Links https://www.medicaid.gov/

Report Generated: Sun Oct 03 03:11:28 EDT 2021 | Page 4